Industry
Medical - Devices
Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Loading...
Open
4.16
Mkt cap
2.6M
Volume
47K
High
4.79
P/E Ratio
-0.01
52-wk high
1372.00
Low
4.15
Div yield
N/A
52-wk low
3.03
Portfolio Pulse from Avi Kapoor
September 03, 2024 | 9:13 am
Portfolio Pulse from Benzinga Insights
September 02, 2024 | 8:31 pm
Portfolio Pulse from Avi Kapoor
August 06, 2024 | 9:16 am
Portfolio Pulse from Benzinga Newsdesk
June 27, 2024 | 1:09 pm
Portfolio Pulse from Benzinga Newsdesk
June 27, 2024 | 1:08 pm
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 3:34 pm
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 12:10 pm
Portfolio Pulse from Benzinga Newsdesk
June 26, 2024 | 12:02 pm
Portfolio Pulse from Benzinga Newsdesk
June 18, 2024 | 11:50 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.